Northern Trust Corp Arvinas, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Arvinas, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 588,493 shares of ARVN stock, worth $11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

588,493

Previous 495,845 18.68%

Holding current value

$11 Million

Previous $13.2 Million 9.81%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$23.66 - $32.73 $2.19 Million - $3.03 Million	92,648 Added 18.68%	588,493 $14.5 Million
Q2 2024 Aug 14, 2024	SELL	$24.46 - $40.4 $324,877 - $536,592	-13,282 Reduced 2.61%	495,845 $13.2 Million
Q1 2024 May 14, 2024	BUY	$36.38 - $52.31 $650,910 - $935,930	17,892 Added 3.64%	509,127 $21 Million
Q4 2023 Feb 13, 2024	BUY	$14.19 - $42.33 $193,523 - $577,296	13,638 Added 2.86%	491,235 $20.2 Million
Q3 2023 Nov 13, 2023	BUY	$19.64 - $28.21 $292,910 - $420,723	14,914 Added 3.22%	477,597 $9.38 Million
Q2 2023 Aug 11, 2023	BUY	$21.73 - $31.43 $295,723 - $427,730	13,609 Added 3.03%	462,683 $11.5 Million
Q1 2023 May 15, 2023	BUY	$26.15 - $37.26 $174,577 - $248,747	6,676 Added 1.51%	449,074 $12.3 Million
Q4 2022 Feb 13, 2023	BUY	$32.47 - $57.24 $85,363 - $150,483	2,629 Added 0.6%	442,398 $15.1 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $110,955 - $153,673	2,650 Added 0.61%	439,769 $19.6 Million
Q2 2022 Aug 12, 2022	BUY	$36.01 - $74.24 $38,062 - $78,471	1,057 Added 0.24%	437,119 $18.4 Million
Q1 2022 May 13, 2022	SELL	$60.27 - $81.57 $915,802 - $1.24 Million	-15,195 Reduced 3.37%	436,062 $29.3 Million
Q4 2021 Feb 08, 2022	BUY	$65.85 - $96.21 $423,283 - $618,437	6,428 Added 1.45%	451,257 $37.1 Million
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $740,930 - $1.09 Million	10,122 Added 2.33%	444,829 $36.6 Million
Q2 2021 Aug 13, 2021	BUY	$60.45 - $84.26 $2.7 Million - $3.76 Million	44,631 Added 11.44%	434,707 $33.5 Million
Q1 2021 May 12, 2021	SELL	$58.19 - $91.37 $91,707 - $143,999	-1,576 Reduced 0.4%	390,076 $25.8 Million
Q4 2020 Feb 11, 2021	BUY	$20.19 - $84.93 $1.19 Million - $5.01 Million	59,046 Added 17.75%	391,652 $33.3 Million
Q3 2020 Nov 16, 2020	BUY	$22.99 - $36.34 $1.62 Million - $2.55 Million	70,282 Added 26.79%	332,606 $7.85 Million
Q2 2020 Aug 14, 2020	SELL	$29.88 - $56.74 $84,889 - $161,198	-2,841 Reduced 1.07%	262,324 $8.8 Million
Q1 2020 May 14, 2020	BUY	$33.0 - $54.5 $109,362 - $180,613	3,314 Added 1.27%	265,165 $10.7 Million
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $604,165 - $1.74 Million	39,257 Added 17.64%	261,851 $10.8 Million
Q3 2019 Nov 13, 2019	BUY	$21.55 - $27.61 $2.46 Million - $3.15 Million	114,268 Added 105.49%	222,594 $4.8 Million
Q2 2019 Aug 13, 2019	BUY	$15.96 - $23.8 $232,984 - $347,432	14,598 Added 15.57%	108,326 $2.38 Million
Q1 2019 May 13, 2019	BUY	$13.55 - $23.79 $234,293 - $411,352	17,291 Added 22.62%	93,728 $1.38 Million
Q4 2018 Feb 12, 2019	BUY	$11.19 - $18.56 $855,330 - $1.42 Million	76,437 New	76,437 $982,000

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $997M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Arvinas, Inc. Transaction History